Target Price | $10.22 |
Price | $3.50 |
Potential |
192.06%
register free of charge
|
Number of Estimates | 9 |
9 Analysts have issued a price target Autolus Therapeutics plc 2025 .
The average Autolus Therapeutics plc target price is $10.22.
This is
192.06%
register free of charge
$13.00
271.43%
register free of charge
$7.00
100.00%
register free of charge
|
|
A rating was issued by 9 analysts: 7 Analysts recommend Autolus Therapeutics plc to buy, 2 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Autolus Therapeutics plc stock has an average upside potential 2025 of
192.06%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million $ | 1.70 | 14.00 |
72.54% | 723.31% | |
EBITDA Margin | -11,085.88% | -1,374.47% |
328.32% | 87.60% | |
Net Margin | -18,780.00% | -1,519.98% |
178.31% | 91.91% |
9 Analysts have issued a sales forecast Autolus Therapeutics plc 2024 . The average Autolus Therapeutics plc sales estimate is
This results in the following potential growth metrics:
6 Analysts have issued an Autolus Therapeutics plc EBITDA forecast 2024. The average Autolus Therapeutics plc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
5 Autolus Therapeutics plc Analysts have issued a net profit forecast 2024. The average Autolus Therapeutics plc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -1.20 | -0.80 |
23.57% | 33.33% | |
P/E | negative | |
EV/Sales | 36.64 |
5 Analysts have issued a Autolus Therapeutics plc forecast for earnings per share. The average Autolus Therapeutics plc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Autolus Therapeutics plc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Autolus Therapeutics plc...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.